Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ANIK stock hub

Anika Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ANIKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

196.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ANIK

In the news

Latest news · ANIK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E64.2

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-7.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-10.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ANIK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000898437
Company name	Anika Therapeutics, Inc.
Country	United States
Country code	US
Cusip	035255108
Employees	235
Employees Change	-53%
Employees Change Percent	-18.4
Enterprise value	$181.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	1993-04-29
Isin	US0352551081
Last refreshed	2026-05-10
Market cap	$196.5M
Market cap category	Micro-Cap
Price	$14.77
Price currency	USD
Rev Per Employee	494,736.17x
Sector	Healthcare
Sic	3841
Symbol	ANIK
Website	https://www.anika.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.63%
EV Sales Forward	1.5x
EV/FCF	174.44x
EV/Sales	1.56x
FCF yield	0.53%
Forward P/E	64.22x
P/B ratio	1.47x
P/S ratio	1.69x
PEG ratio	6.42x
PS Forward	1.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10.54%
EBITDA Margin	-5.9%
FCF margin	0.89%
Gross margin	58.59%
Gross Profit	$68.1M
Gross Profit Growth	-5.79%
Gross Profit Growth Q	29.4%
Gross Profit Growth3 Y	-11.36%
Gross Profit Growth5 Y	-3.71%
Net Income	$-11.1M
Net Income Growth Years	2%
Pretax Margin	-8.82%
Profit Margin	-9.52%
Profit Per Employee	$-47,077
ROA	-4.14
Roa5y	-1.2
ROCE	-7.74
ROE	-7.85
Roe5y	-2.13
ROIC	-10.62
Roic5y	-3.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-10.35%
Cagr15y	4.81%
Cagr1y	1.93%
Cagr20y	1.55%
Cagr3y	-17.04%
Cagr5y	-18.86%
EPS Growth Years	2
FCF Growth5 Y	-33.95%
OCF Growth	19.87%
OCF Growth10 Y	-17.28%
OCF Growth3 Y	34.5%
OCF Growth5 Y	-7.56%
Revenue Growth	-0.68x
Revenue Growth Q	13.16x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-9.62x
Revenue Growth5 Y	-2.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.63
Assets	$179.4M
Cash	$41M
Current Assets	$93.6M
Current Liabilities	$21M
Debt	$25.7M
Debt Equity	$0.19
Debt FCF	$24.77
Equity	$133.9M
Liabilities	$45.5M
Long Term Assets	$85.8M
Long Term Liabilities	$24.5M
Net Cash	$15.3M
Net Cash By Market Cap	$7.78
Net Cash Growth	-45.29%
Net Debt Equity	$-0.11
Net Debt FCF	$-14.71
Tangible Book Value	$124.4M
Tangible Book Value Per Share	$9.31
WACC	4.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.46
Inventory Turnover	2.18
Net Working Capital	$33.5M
Quick ratio	3.19
Working Capital	$72.6M
Working Capital Turnover	$1.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.24%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-66.45%
1Y total return	1.93%
200-day SMA	10.79
3Y total return	-42.91%
50-day SMA	14.68
50-day SMA vs 200-day SMA	50over200
5Y total return	-64.82%
All Time High	75.72
All Time High Change	-80.49%
All Time High Date	2019-10-25
All Time Low	0.69
All Time Low Change	2,048.36%
All Time Low Date	2000-12-29
ATR	0.84
Beta	0.16
Beta1y	1.11
Beta2y	0.9
Ch YTD	53.69
High	15.36
High52	16.24
High52 Date	2026-04-20
High52ch	-9.05%
Low	14.76
Low52	7.87
Low52 Date	2025-07-31
Low52ch	87.68%
Ma50ch	0.63%
Price vs 200-day SMA	36.85%
RSI	50.59
RSI Monthly	47.97
RSI Weekly	66.57
Sharpe ratio	0.29x
Sortino ratio	0.48
Total Return	3.24%
Tr YTD	53.69
Tr15y	102.33%
Tr1m	-1.01%
Tr1w	-0.54%
Tr3m	41.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.04
Earnings Revenue Estimate	28,141,600x
Earnings Revenue Estimate Growth	7.54x
Operating Income	$-12.3M
Operating margin	-10.54
Price target	$17
Price Target Change	$15.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,295,585%
Float Percent	84.89%
Shares Insiders	4.32%
Shares Institutions	82.35%
Shares Out	13,305,624
Shares Qo Q	-7.76%
Shares Yo Y	-3.24%
Short Float	5.71%
Short Ratio	4.97
Short Shares	4.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.8M
Average Volume	132,532.9x
Bv Per Share	10.02
CAPEX	$-5.4M
Ch10y	-66.45
Ch15y	102.3
Ch1m	-1.01
Ch1w	-0.54
Ch1y	1.93
Ch20y	35.88
Ch3m	41.21
Ch3y	-42.91
Ch5y	-64.82
Ch6m	49.95
Change	-2.44%
Change From Open	-2.19
Close	15.14
Days Gap	-0.26
Depreciation Amortization	5,395,000
Dollar Volume	1,121,944
Earnings Date	2026-04-29
Earnings Time	bmo
EBIT	$-12.3M
EBITDA	$-6.9M
EPS	$-0.78
F Score	3
FCF	$1M
FCF EV Yield	0.57x
FCF Per Share	$0.08
Financing CF	-15,460,000
Fiscal Year End	December
Founded	1,983
Goodwill	7,892,000
Income Tax	$818,000
Investing CF	-3,312,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	11.38
Ma150ch	29.81%
Ma20	14.97
Ma20ch	-1.33%
Net CF	-12,351,000
Next Earnings Date	2026-07-29
Open	15.1
Optionable	Yes
P FCF Ratio	189.1
P OCF Ratio	30.37
Position In Range	1.67
Post Close	14.77
Postmarket Change Percent	0.07
Postmarket Price	$14.78
Ppne	65,152,000
Price Date	2026-05-08
Ptbv Ratio	1.58
Relative Volume	0.57x
Revenue	116,263,000x
SBC By Revenue	11.92x
Share Based Comp	13,862,000
Tax By Revenue	0.7x
Tr20y	35.88%
Tr6m	49.95%
Us State	Massachusetts
Volume	75,961
Z Score	3.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ANIK pay a dividend?

Capital-return profile for this ticker.

Performance

ANIK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ANIK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.4%

Float: +84.9% of shares outstanding

Insider ownership

+4.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ANIK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.6

Neutral momentum band

Price vs 200-day MA

+36.8%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

0.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ANIK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ANIK stock rating?

Anika Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ANIK analysis?

The full report lives at /stocks/ANIK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ANIK?

The latest report frames ANIK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ANIK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.